Skip to main content
. 2018 Apr 28;39(7):931–936. doi: 10.1093/carcin/bgy052

Table 1.

Clinical evidence of RAS/GEF GTP pathway associated with glioblastoma (GB)

Gene Cancer type Fold change
(GB/Normal)
P-value Gene rank Data set (number of patients) Ref
CTNNAL1 Glioblastoma versus normal 2.177 1.51E−11 79 TCGA Brain (557) TCGA
Glioblastoma versus normal 2.984 1.42E−16 266 Sun Brain (180) (17)
Glioblastoma versus normal 1.432 9.08E−04 1648 Bredel Brain 2 (54) (16)
ASAP1 Glioblastoma versus normal 1.181 0.003 1321 Freije Brain (85) (30)
Glioblastoma versus normal 1.777 0.036 293 Liang Brain (38) (15)
Secondary glioblastoma versus normal 1.157 0.002 1186 DNA Beroukhim Brain (187) (31)
Glioblastoma versus normal 1.034 1.79E−10 1605 DNA TCGA Brain 2 (1,531) TCGA
Glioblastoma versus normal 1.478 3.45E−06 2068 Sun Brain (180) (17)
Glioblastoma versus normal 4.916 5.15E−26 10 TCGA Brain (557) TCGA
CD44 Glioblastoma versus normal 7.243 1.17E−15 21 Bredel Brain 2 (54) (16)
Glioblastoma versus normal 4.142 3.36E−09 35 Liang Brain (38) (15)
Glioblastoma versus normal 6.456 3.30E−23 77 Sun Brain (180) (17)
Glioblastoma versus normal 3.592 3.46E−08 81 Shai Brain (42) (32)
Glioblastoma versus normal 2.591 7.09E−18 86 Murat Brain (84) (33)
Glioblastoma versus normal 3.14 1.47E−04 907 Lee Brain (101) (34)